OraSure Technologies stock sits 26.33 percent above USD 3.00 target
Published on 10/20/2026 at 20:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- MarketBeat listed a USD 3.00 consensus target and a Reduce rating on October 15, 2026.
- OraSure reported USD 30.64 million revenue and USD 6.76 million net income for the second quarter of 2026.
- OraSure Technologies stock costs EUR 3.37 at Lang & Schwarz on October 20, 2026 at 8:05 p.m. CEST, with Nasdaq trading up 2.95 percent.
- Barron's lists November 10, 2026, for the third-quarter 2026 report.
OraSure Technologies stock sits 26.33 percent above the USD 3.00 consensus target listed by MarketBeat on October 15, 2026. The rating was Reduce, based on two Hold ratings and one Sell rating. OraSure Technologies was trading at EUR 3.37 at Lang & Schwarz on October 20, 2026 at 8:05 p.m. CEST.
Second-quarter profit changed the picture
OraSure reported USD 30.64 million of revenue for the second quarter ended June 30, 2026, up from USD 27.93 million in the first quarter. Net income reached USD 6.76 million, compared with a USD 23.27 million loss in the first quarter. The figures come from the company's investor materials and standardized quarterly statement, with the company description and reporting period available through OraSure Technologies.
Price remains below the yearly high
The Nasdaq quote was USD 3.79 at 2:11 p.m. EDT on October 20, 2026, up 2.95 percent from USD 3.68. Trading volume was 136,727 shares. The 52-week range was USD 2.08 to USD 4.58, leaving the stock 17.25 percent below its high and 82.21 percent above its low.
The euro quote and the Nasdaq quote describe separate venues. The Lang & Schwarz price gives German investors the euro view, while Nasdaq remains OraSure's primary listing. Market capitalization stood at USD 261.3 million, and the trailing P/E ratio was minus 5.49 on October 20, 2026.
What date matters next?
Barron's lists November 10, 2026, for OraSure's third-quarter 2026 earnings report. Its quarterly estimate is a loss of USD 0.23 per share. That date gives the USD 3.00 consensus target a near-term test, while the second-quarter profit provides the latest operating comparison.
Price and valuation in context
OraSure's second-quarter operating margin was 18.00 percent, following a negative 83.00 percent margin in the first quarter. Operating cash flow was negative USD 9.92 million in the second quarter, so the earnings improvement did not yet translate into positive operating cash generation.
Stock position for investors
The central contrast is clear: quarterly net income improved to USD 6.76 million, but the company still carried negative operating cash flow and a consensus rating of Reduce. The stock's EUR 3.37 Lang & Schwarz quote also sits below the Nasdaq equivalent of USD 3.79, reflecting different currencies and venues rather than a single combined price.
The further course of trading is shown by the continuously updated real-time quote of OraSure Technologies stock.
OraSure Technologies market data
- Company: OraSure Technologies, Inc.
- ISIN: US68554V1089
- Ticker: OSUR
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 20, 2026, 8:05 p.m. CEST): EUR 3.37
- Nasdaq change: plus 2.95 percent on October 20, 2026
- Market capitalization: USD 261.3 million (as of October 20, 2026)
- 52-week range: USD 2.08-4.58 (as of October 20, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
- Next earnings date: November 10, 2026
Market context: Market report Nasdaq Composite.
